Skip to content

Molecular Mechanisms of Chondrocyte Degeneration in Knee Osteoarthritis

Molecular Mechanisms of Chondrocyte Degeneration in Knee Osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118529
Enrollment
Unknown
Registered
2026-02-06
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

Group 1:Participants will maintain their habitual lifestyle throughout the study period and will not receive any structured exercise intervention, including resistance training or aerobic training. On
Group 2:Participants will undergo a structured upper-limb resistance training program targeting the major upper-limb skeletal muscle groups, including the biceps brachii, triceps brachii, deltoid, pec
Group 3:Participants will undergo a structured lower-limb resistance training program targeting the major lower-limb skeletal muscle groups, including the quadriceps, hamstrings, gluteus maximus, and

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed with knee osteoarthritis, with the Kellgren-Lawrence grade of the affected knee confirmed by imaging as grade IV, or proposed to receive total knee arthroplasty (TKA) treatment after preoperative assessment; Or have symptoms related to knee osteoarthritis, and have the ability to participate in exercise intervention experiments; 2. No serious neurological, cardiovascular, respiratory or mental system diseases, and passed the preoperative/pre-exercise safety screening assessment; 3. No glucocorticoid drug treatment was received within 3 months before the operation; 4. No history of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus; 5. No history of active infection or malignant tumor; 6. Be capable of cooperating to complete the process of biological sample collection or exercise intervention; 7. Understand the purpose and process of this study and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus; 2. Within 3 months before the operation, received glucocorticoids, intra-articular injections or other treatments that might affect the research results; 3. Those with severe cardiovascular, neurological or mental system diseases who cannot tolerate exercise or surgery; 4. Have cognitive impairments, poor compliance, and are unable to complete the research process or cooperate with the follow-up. 5. Those with active infections or those who have recently undergone major joint surgery; 6. Other circumstances where the researcher deems it inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Weight;Height;Clinical score;Body composition;

Secondary

MeasureTime frame
age;gender;Maximal oxygen uptake;

Countries

China

Contacts

Public ContactGu Cheng

The First Affiliated Hospital of Sun Yat-sen University

guch8@mail2.sysu.edu.cn+86 132 2548 8054

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026